After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Drug Manufacturers – Specialty & Generic industry segment. The current market capitalization of Kiniksa Pharmaceuticals International Plc is $2.85B. A total of 0.61 million shares were traded on the day, compared to an average of 535.82K shares.
In the most recent transaction, Tessari Eben sold 42,000 shares of KNSA for 38.33 per share on Sep 29 ’25. After the transaction, the CHIEF OPERATING OFFICER now owns 34,552 company shares. In a previous transaction on Sep 29 ’25, Tessari Eben bought 42,000 shares at 38.33 per share.
Among the insiders who sold shares, Tessari Eben disposed of 16,400 shares on Sep 15 ’25 at a per-share price of $36.46. This resulted in the CHIEF OPERATING OFFICER holding 34,552 shares of KNSA after the transaction. In another insider transaction, Tessari Eben bought 16,400 shares at $36.46 per share on Sep 15 ’25.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, KNSA has a high of $39.12 and a low of $17.82.
As of this writing, KNSA has an earnings estimate of $0.37 per share for the current quarter. EPS was calculated based on a consensus of 5.0 estimates, with a high estimate of $0.56 per share and a lower estimate of $0.26. The company reported an EPS of -$0.18 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. KNSA’s latest balance sheet shows that the firm has $182.20M in Cash & Short Term Investments as of fiscal 2021. There were $6.05M in debt and $44.82M in liabilities at the time. Its Book Value Per Share was $6.69, while its Total Shareholder’s Equity was $185.04M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for KNSA is Buy with a score of 5.00.
